Department of Veterinary Pathobiology, Texas A&M University, College Station, Texas.
Department of Nutrition and Food Science, Texas A&M University, College Station, Texas.
Ann N Y Acad Sci. 2019 Apr;1441(1):8-16. doi: 10.1111/nyas.14058.
Globally, increasing acquired antimicrobial resistance among pathogenic bacteria presents an urgent challenge to human and animal health. As a result, significant efforts, such as the One Health Initiative, are underway to curtail and optimize the use of critically important antimicrobials for human medicine in all applications, including food animal production. This review discusses the rationale behind multiple and competing "critically important antimicrobial" lists and their contexts as created by international, regional, and national organizations; identifies discrepancies among these lists; and describes issues surrounding risk management recommendations that have been made by regulatory organizations on the use of antibiotics in food animal production. A more harmonized approach to defining criticality in its various contexts (e.g., for human versus animal health, enteric diseases versus other systemic infections, and direct versus indirect selection of resistance) is needed in order to identify shared contextual features, aid in their translation into risk management, and identify the best ways to maintain the health of food animals, all while keeping in mind the wider risks of antimicrobial resistance, environmental impacts, and animal welfare considerations.
在全球范围内,致病细菌获得性抗药性的增加对人类和动物健康构成了紧迫的挑战。因此,正在进行重大努力,如“同一健康倡议”,以遏制和优化人类医学中所有应用(包括食用动物生产)中重要的抗菌药物的使用。本文讨论了由国际、地区和国家组织制定的多个相互竞争的“重要抗菌药物”清单及其背景的基本原理;确定了这些清单之间的差异;并描述了监管机构就食用动物生产中抗生素使用提出的风险管理建议所涉及的问题。需要采取更加协调的方法来定义各种情况下的关键性(例如,对于人类健康与动物健康、肠道疾病与其他全身感染、直接与间接选择耐药性),以便确定共同的上下文特征,有助于将其转化为风险管理,并确定维持食用动物健康的最佳方法,同时牢记更广泛的抗药性、环境影响和动物福利方面的风险。